Table 5.
Characteristics of all isolates from V2A, V2A-Ag, V2A-AGXX® after 6, 12, and 19 months.
| No. | Name | Species | Biofilm formation | AB-R | Number of plasmid-bands >20 kbp | |
|---|---|---|---|---|---|---|
| Phenotype | Genotype | |||||
| 1 | V2A-6-01 | S. hominis | +++ | AMP10, DA10, E15, RL25 | n.d. | n.d. |
| 2 | V2A-6-02 | S. hominis | ++ | DA10, E15, RL25 | ermC | n.d. |
| 3 | V2A-6-03 | S. hominis | +++ | AMP10, DA10, E15, RL25 | ermC | 1 |
| 4 | V2A-6-04 | S. hominis | +++ | DA10, E15, RL25 | n.d. | n.d. |
| 5 | V2A-6-05 | S. hominis | +++ | AMP10, E15, RL25, TE10 | tetK, ermC | 2 |
| 6 | V2A-6-06 | S. hominis | ++ | AMP10, E15, RL25, TE10 | tetK, tetO, ermC | 2 |
| 7 | V2A-6-07 | S. hominis | ++ | AMP10, E15, RL25, TE10 | tetK, ermC | 1 |
| 8 | V2A-6-08 | S. hominis | ++ | DA10, E15, RL25 | n.d. | n.d. |
| 9 | V2A-6-09 | S. hominis | +++ | AMP10, DA10, E15, RL25 | tetK | 2 |
| 10 | V2A-6-10 | S. hominis | +++ | AMP10, E15, RL25, TE10 | n.d. | 0 |
| 11 | V2A-6-11 | S. hominis | +++ | AMP10, E15, RL25, TE10 | ermC | 1 |
| 12 | V2A-6-12 | S. hominis | +++ | AMP10, E15, RL25, TE10 | ermC | 1 |
| 13 | V2A-6-13 | S. aureus | +++ | AMP10, E15, K5, RL25 | ermC | 1 |
| 14 | V2A-6-14 | S. aureus | +++ | AMP10, DA10, E15, K5, RL25 | tetK | 0 |
| 15 | V2A-6-15 | S. hominis | +++ | AMP10, E15, RL25, TE10 | ermC | 1 |
| 16 | V2A-6-16 | S. aureus | ++ | AMP10, E15, K5, RL25, TE10 | ermC | n.d. |
| 17 | V2A-AG-6-01 | S. epidermidis | +++ | E15, RL25 | ermC | n.d. |
| 18 | V2A-AG-6-02 | S. epidermidis | +++ | E15, RL25 | n.d. | n.d. |
| 19 | V2A-AG-6-03 | S. aureus | +++ | AMP10, E15, RL25 | ermC | n.d. |
| 20 | V2A-AG-6-04 | S. aureus | +++ | AMP10, E15, RL25 | ermC | n.d. |
| 21 | V2A-AG-6-05 | S. aureus | +++ | AMP10, E15, K5, RL25 | n.d. | n.d. |
| 22 | V2A-AG-6-06 | S. epidermidis | +++ | E15, RL25 | n.d. | n.d. |
| 23 | V2A-AG-6-07 | S. aureus | ++ | AMP10, E15, RL25 | n.d. | n.d. |
| 24 | V2A-AG-6-09 | S. epidermidis | +++ | E15, RL25 | n.d. | n.d. |
| 25 | V2A-AG-6-11 | S. aureus | +++ | AMP10, E15, RL25 | n.d. | n.d. |
| 26 | V2A-AG-6-14 | S. aureus | +++ | AMP10, E15, RL25 | n.d. | n.d. |
| 27 | V2A-AG-6-15 | S. epidermidis | +++ | AMP10, E15, RL25 | n.d. | n.d. |
| 28 | V2A-AG-6-16 | S. epidermidis | +++ | E15, RL25 | ermC | n.d. |
| 29 | V2A-AG-6-21 | S. epidermidis | +++ | E15, RL25 | n.d. | n.d. |
| 30 | V2A-AG-6-22 | S. epidermidis | +++ | E15, RL25 | n.d. | n.d. |
| 31 | V2A-AG-6-23 | S. epidermidis | +++ | AMP10, E15, RL25 | n.d. | n.d. |
| 32 | V2A-AG-6-24 | S. epidermidis | +++ | E15, RL25 | n.d. | n.d. |
| 33 | V2A-12-02 | S. hominis | ++ | AMP10, E15, MEM10, RL25 | n.d. | n.d. |
| 34 | V2A-12-03 | E. faecalis | +++ | C30, CN10, DA10, DO30, E15, K5, MEM10, RL25, TE10 | aac6-aph2a, aph3-III, ermC | 1 |
| 35 | V2A-12-04 | S. hominis | +++ | AMP10, E15, K5, RL25, TE10 | aph3-III, tetO | 1 |
| 36 | V2A-AGXX-12-01 | S. hominis | +++ | AMP10, E15, RL25, TE10 | tetK, tetL | 1 |
| 37 | V2A-AG-12-03 | S. hominis | +++ | AMP10, K5, RL25 | aadD, aph3-III | 1 |
| 38 | V2A-AG-12-04 | S. hominis | +++ | AMP10 | n.d. | n.d. |
| 39 | V2A-AG-12-05 | S. hominis | +++ | AMP10, E15, K5, MEM10, RL25 | aph3-III, aadD, ermC | 0 |
| 40 | V2A-AGXX-12-02 | E. faecalis | +++ | CN10, DO30, K5, RL25 | aph(2)-ic, aph3-III, aadD | 1 |
| 41 | V2A-AGXX-12-03 | E. faecalis | +++ | CN10, DA10, E15, K5, RL25, TE10 | aph(2)-ic, aadD, aph3-III, ermB, tetK, tetM, tetO | 1 |
| 42 | V2A-AG-12-06 | S. hominis | +++ | AMP10, DO30, E15, RL25, TCG15, TE10 | tetK | 1 |
| 43 | V2A-12-07 | S. epidermidis | +++ | AMP10, DO30, RL25 | n.d. | n.d. |
| 44 | V2A-AGXX-12-05 | S. haemolyticus | +++ | C30, DO30, E15, RL25, TE10 | tetO | 3 |
| 45 | V2A-AG-12-08 | S. hominis | +++ | AMP10, DA10, E15, RL25 | ermC | 2 |
| 46 | V2A-12-08 | S. haemolyticus | +++ | C30, DO30, E15, RL25, TE10 | tetK | 1 |
| 47 | V2A-AG-12-10 | S. hominis | +++ | RL25 | n.d. | n.d. |
| 48 | V2A-12-09 | S. lugdunensis | +++ | RL25 | n.d. | n.d. |
| 49 | V2A-AGXX-12-06 | S. hominis | +++ | AMP10, DA10, E15, RL25 | ermC | 1 |
| 50 | V2A-AGXX-12-09 | S. hominis | +++ | AMP10, RL25 | n.d. | n.d. |
| 51 | V2A-12-10 | S. caprae | +++ | AMP10, C30, E15, RL25 | ermC | n.d. |
| 52 | V2A-12-12 | S. lugdunensis | +++ | RL25 | 0 | 0 |
| 53 | V2A-12-13 | S. hominis | +++ | AMP10, DA10, RL25 | n.d. | n.d. |
| 54 | V2A-19-02 | S. hominis | ++ | AMP10, E15, RL25 | n.d. | n.d. |
| 55 | V2A-AGXX-19-01 | S. epidermidis | + | E15, RL25 | n.d. | n.d. |
| 56 | V2A-19-03 | S. hominis | +++ | E15, RL25 | n.d. | n.d. |
| 60 | V2A-19-05 | S. hominis | +++ | E15, RL25 | n.d. | n.d. |
| 61 | V2A-19-06 | S. hominis | +++ | E15, RL25 | n.d. | n.d. |
| 62 | V2A-19-07 | S. hominis | +++ | E15, RL25 | n.d. | n.d. |
| 63 | V2A-AG-19-06 | S. hominis | +++ | RL25 | n.d. | n.d. |
| 64 | V2A-19-09 | S. hominis | +++ | E15, RL25 | n.d. | n.d. |
| 65 | V2A-19-10 | S. hominis | +++ | E15, RL25 | n.d. | n.d. |
| 66 | V2A-AG-19-07 | S. hominis | +++ | E15, RL25 | n.d. | n.d. |
| 67 | V2A-AG-19-08 | S. hominis | +++ | E15, RL25 | n.d. | n.d. |
| 68 | V2A-19-14 | B. cereus | +++ | AMP10, K5, OX5, RL25 | n.d. | n.d. |
| 69 | V2A-19-15 | B. cereus | + | AMP10, K5, OX5, RL25 | n.d. | n.d. |
| 70 | V2A-AG-19-10 | B. cereus | + | AMP10, C30, E15, K5, OX5, RL25 | n.d. | n.d. |
| 71 | V2A-19-16 | B. cereus | + | AMP10, OX5, RL25, TCG15 | n.d. | n.d. |
| 72 | V2A-19-17 | B. cereus | ++ | AMP10, K5, OX5, RL25 | n.d. | n.d. |
| 73 | V2A-19-18 | B. cereus | + | AMP10, OX5 | n.d. | n.d. |
| 74 | V2A-AG-19-12 | B. cereus | + | AMP10, OX5, RL25 | n.d. | n.d. |
| 75 | V2A-19-19 | B. cereus | ++ | AMP10, OX5, RL25 | n.d. | n.d. |
| 76 | V2A-19-20 | B. cereus | ++ | AMP10, OX5, RL25 | n.d. | n.d. |
| 77 | V2A-AG-19-14 | B. cereus | + | AMP10, E15, OX5, RL25 | n.d. | n.d. |
| 78 | V2A-AGXX-19-03 | B. cereus | + | AMP10, OX5, RL25 | n.d. | n.d. |
AB-R, antibiotic resistance; +++, strong biofilm formation; ++, moderate biofilm formation; +, weak biofilm formation; AMP, ampicillin; C, chloramphenicol; CN, gentamicin; DA, clindamycin; DO, doxycycline; E, erythromycin; K, kanamycin; MEM, meropenem; OX, oxacillin; RL, sulfamethoxazole; TCG, tigecycline; TE, tetracycline. The concentration of the antibiotics is given in μg/mL. ermC, ermB, erythromycin resistance genes; aac6-aph2a, aph(2)-ic, gentamicin resistance genes; blaSHV-5, ß-lactam antibiotic resistance gene; aadD, aph3-III, kanamycin resistance genes; tetK, tetM, tetL, tetO, tetracycline resistance genes. n.d., not determined.